Cargando…
Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
BACKGROUND: Nicorandil, as an adjunctive therapy with primary percutaneous coronary intervention (PCI), had controversial benefits in cardioprotection in patients with acute myocardial infarction (AMI). METHODS AND RESULTS: We performed a systematic review of randomized controlled trials (RCTs) comp...
Autores principales: | Wu, Muli, Huang, Zheng, Xie, Haojun, Zhou, Zhongjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805586/ https://www.ncbi.nlm.nih.gov/pubmed/24167609 http://dx.doi.org/10.1371/journal.pone.0078231 |
Ejemplares similares
-
Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction
por: Feng, Chunguang, et al.
Publicado: (2018) -
Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial
por: Qian, Geng, et al.
Publicado: (2022) -
Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Himanshu, et al.
Publicado: (2022) -
Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
por: Zhao, Xiao-Tao, et al.
Publicado: (2019) -
Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis
por: Zhou, Jin, et al.
Publicado: (2020)